nach oben

Erschienen in:

Open Access 01.12.2020 | COVID-19 | Educational Review

COVID-19 pneumonia: the great radiological mimicker

verfasst von: Selin Ardali Duzgun, Gamze Durhan, Figen Basaran Demirkazik, Meltem Gulsun Akpinar, Orhan Macit Ariyurek

Erschienen in: Insights into Imaging | Ausgabe 1/2020

Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly spread worldwide since December 2019. Although the reference diagnostic test is a real-time reverse transcription-polymerase chain reaction (RT-PCR), chest-computed tomography (CT) has been frequently used in diagnosis because of the low sensitivity rates of RT-PCR. CT findings of COVID-19 are well described in the literature and include predominantly peripheral, bilateral ground-glass opacities (GGOs), combination of GGOs with consolidations, and/or septal thickening creating a “crazy-paving” pattern. Longitudinal changes of typical CT findings and less reported findings (air bronchograms, CT halo sign, and reverse halo sign) may mimic a wide range of lung pathologies radiologically. Moreover, accompanying and underlying lung abnormalities may interfere with the CT findings of COVID-19 pneumonia. The diseases that COVID-19 pneumonia may mimic can be broadly classified as infectious or non-infectious diseases (pulmonary edema, hemorrhage, neoplasms, organizing pneumonia, pulmonary alveolar proteinosis, sarcoidosis, pulmonary infarction, interstitial lung diseases, and aspiration pneumonia). We summarize the imaging findings of COVID-19 and the aforementioned lung pathologies that COVID-19 pneumonia may mimic. We also discuss the features that may aid in the differential diagnosis, as the disease continues to spread and will be one of our main differential diagnoses some time more.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

CMV

Cytomegalovirus

COVID-19

Coronavirus disease 2019

Computed tomography

DIP

Desquamative interstitial pneumonia

GGO

Ground-glass opacity

HMPV

Human metapneumovirus

ICU

Intensive care unit

LIP

Lymphocytic interstitial pneumonia

MERS

Middle East respiratory syndrome virus

NSIP

Non-specific interstitial pneumonia

PAP

Pulmonary alveolar proteinosis

PJP

Pneumocystis jirovecii pneumonia

RILD

Radiotherapy-induced lung disease

RSV

Respiratory syncytial virus

RT-PCR

Real-time reverse transcription-polymerase chain reaction

SARS

Severe acute respiratory syndrome virus

SARS-CoV-2

Severe acute respiratory syndrome coronavirus 2

WHO

World Health Organization

Introduction

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, was found to be associated with a pneumonia outbreak firstly reported in Wuhan, China, in December 2019 [1, 2]. The disease subsequently called Coronavirus Disease 2019 (COVID-19) has caused a lot of cases worldwide and was declared as a pandemic by the World Health Organization (WHO) on March 11, 2020 [3].

The reference diagnostic test for COVID-19 pneumonia is real-time reverse transcription-polymerase chain reaction (RT-PCR). The specificity of RT-PCR is approximately 95%, but the sensitivity of RT-PCR at the initial presentation is 60–71% because of kit performance, sampling and transportation limitations [4‐6]. Because of these low sensitivity rates and the need for rapid diagnosis, non-contrast chest-computed tomography (CT) has been frequently used in the current pandemic condition. Also, several cases with initial negative RT-PCR results are reported to have positive chest CT findings [4]. Although recent studies have reported the high sensitivity of chest CT for diagnosis with RT-PCR as a reference, the specificity of CT is relatively low. In a recent meta-analysis, chest CT had a pooled sensitivity of 94% and a specificity of 37% [4, 5, 7]. This may be explained by the fact that besides previously reported typical appearance, COVID-19 has various CT findings, and some chest CT findings of COVID-19 may closely resemble the imaging findings of some other pathologies presenting with airspace disease.

In this pictorial review, CT findings of COVID-19 pneumonia and imaging features of COVID-19 pneumonia that may mimic other infectious and non-infectious diseases will be summarized.

CT findings of COVID-19 pneumonia

Typical CT findings of COVID-19 pneumonia are predominantly peripheral, bilateral ground-glass opacities (GGOs), consolidations, combination of GGOs with consolidations, and GGOs superimposed with interlobular/intralobular septal thickening creating a “crazy-paving” pattern and subpleural linear opacities. Air bronchograms, vascular enlargement, CT halo sign, and reverse halo sign are also reported. Cavitation, pleural or pericardial effusion, and lymphadenopathy are rarely observed [8‐11].

Findings vary and usually progress during the course of the disease. In the early phase, the predominant finding is unilateral or bilateral small peripheral GGOs. While the size and number of GGOs and the number of affected lobes increase, crazy-paving pattern and consolidations appear as the disease progresses. Consolidations become denser at the peak stage (Fig. 1). Approximately after 2 weeks, opacities start to resolve gradually, and residual subpleural curvilinear lines, fibrous stripes, and GGOs may be seen [9, 12, 13].

Infectious causes

Differentiation of COVID-19 pneumonia from other causes of infection is sometimes challenging, especially when it comes to viral pneumonia and other atypical pneumonia. Bai et al. reported some findings in favor of COVID-19 pneumonia rather than non-COVID pneumonia, such as the presence of GGOs, peripheral distribution, reverse halo sign, and vascular enlargement. Pleural effusion and thickening, lymphadenopathy, and central distribution are less likely to be seen in COVID-19 pneumonia [14]. By contrast, some typical findings described for COVID-19 pneumonia can be seen in non-COVID pneumonia or other pathologies. For example, both the reverse halo sign and CT halo sign have also been previously described in fungal infections and tuberculosis [15‐17].

The diagnostic association of CT findings for different infectious diseases is summarized in Table 1.

Table 1

CT findings of COVID-19 pneumonia and other infectious diseases

CT finding	COVID-19 pneumonia	Non-COVID viral pneumonia	Bacterial pneumonia	PJP	Fungal pneumonia
GGO	+++	++	+	+++	+
Consolidation	++	++	+++	0	+
Centrilobular nodular opacities	−−−	++	++	−	+
Crazy-paving	++	++	+	++	−
Lesion distribution
Peripheral	+++	++	+	+	0
Lower zone	+++	++	+	+	0
Rounded morphology	+++	+	+	−−	++
Cavitation	−−−	−	+	−	++
Pleural effusion	−−	+	++	0	+
Lymphadenopathy	−−	+	++	0	+

The most common findings of aforementioned disease groups are presented. Signs indicate the strength of relation between the CT finding and diagnosis; in a range of (+++) and (−−−); (+++) indicating the strongest association

Viral pneumonia

Chest CT findings of a wide range of viruses have been previously described, such as influenza virus, parainfluenza virus, adenovirus, respiratory syncytial virus (RSV), cytomegalovirus (CMV), human metapneumovirus (HMPV), and other coronaviruses. Viral pneumonia commonly manifests as interstitial pneumonia with nonspecific imaging findings, such as GGOs, patchy consolidations, peribronchovascular thickening, centrilobular nodular opacities, a “tree-in-bud” pattern, and interlobular septal thickening [18, 19] (Fig. 2). Unlike in other viral pneumonia, centrilobular nodular opacities are not common in COVID-19 pneumonia.

Some typical findings of COVID-19 pneumonia, such as the subpleural distribution of opacities and a crazy-paving pattern, were also described for pneumonia caused by other coronaviruses, severe acute respiratory syndrome virus (SARS), and middle east respiratory syndrome virus (MERS), that caused outbreaks previously [20‐22]. The absence of cavitation, pleural effusion, and lymphadenopathy are common in both COVID-19 pneumonia and SARS [20].

Bacterial pneumonia

Although viral and bacterial pneumonia have overlapping imaging findings, the latter generally causes lobar/segmental pneumonia or bronchopneumonia and focal or multifocal consolidations. Less commonly, GGOs may be seen. Peribronchial thickening, centrilobular nodular opacities, and pleural effusion are much more frequent in bacterial pneumonia than in COVID-19 pneumonia [18, 23] (Fig. 2).

Pneumocystis jirovecii pneumonia (PJP)

GGOs and crazy-paving pattern are also predominant in PJP, especially in an immunosuppressed host. Relative central lung involvement, upper lobe predilection, and pulmonary cysts in PJP, unlike in COVID-19 pneumonia, can help in differential diagnosis [24] (Fig. 2).

Fungal pneumonia

Fungal pneumonia may have various imaging findings, such as GGOs, nodular opacities, a tree-in-bud pattern, and cavitating consolidations [25, 26]. A CT halo sign in which the surrounding GGOs represent hemorrhage has been commonly described in angioinvasive aspergillosis. In addition, a CT halo sign may be seen in candidiasis, cryptococcosis, and coccidioidomycosis [17, 26]. The reverse halo sign was previously reported in mucormycosis, invasive pulmonary aspergillosis, paracoccidioidomycosis, histoplasmosis, and cryptococcosis [15]. Although some CT findings of fungal pneumonia overlap with those of COVID-19 pneumonia, the presence of centrilobular nodular opacities, cavitation, chest wall invasion, pleural effusion, and lymphadenopathy favor the diagnosis of a fungal infection [25, 26] (Fig. 3).

Super-infection/co-infection

A recent meta-analysis reported bacterial and viral co-infection rates among hospitalized COVID-19 patients as 7% and 3%, respectively. Moreover, intensive care unit (ICU) patients showed a higher bacterial co-infection rate (14%) [27]. Although COVID-19 pneumonia may mimic other lung infections, the presence of atypical findings, such as pleural effusion, lymphadenopathy, lobar consolidation, or centrilobular nodular opacities, should raise a concern about super-infection or co-infection in patients diagnosed with COVID-19 pneumonia [18] (Fig. 4).

Non-infectious causes

The diagnostic association of CT findings for COVID-19 pneumonia and different non-infectious differential diagnoses are summarized in Table 2.

Table 2

CT findings of COVID-19 pneumonia and non-infectious diseases

CT finding	COVID-19 pneumonia	Pulmonary Edema	Pulmonary Hemorrhage	Neoplasms	Organizing pneumonia	PAP	Sarcoidosis	Infarction	Interstitial diseases	Aspiration pneumonia
GGO	+++	+++	+++	+	++	+++	+	+	++	+
Consolidation	++	++	++	++	++	++	+	++	+	++
Centrilobular nodular opacities	−−−	−	+	+	0	−−	++	−−−	+	++
Crazy-paving	++	+	++	+	+	+++	+	−−−	+	0
Lesion distribution
Peripheral	+++	−−	+	+	++	−	0	+++	++	++
Lower zone	+++	+	+	+	++	0	−	++	++	+++
Rounded morphology	+++	−	++	++	+	−	+	+	0	+
Cavitation	−−−	−−−	0	+	−	−	−	+	−−	++
Pleural effusion	−−	++	+	++	−	−−	−	++	−	+
Lymphadenopathy	−−	+	0	++	0	−	+++	0	+	+

Pulmonary edema

In pulmonary edema, diffuse or patchy GGOs can be observed similar to those in COVID-19 pneumonia. However, the central and gravitational predominance of GGOs and the other accompanying findings, such as interlobular septal thickening, vascular redistribution, peribronchovascular cuffing, cardiomegaly, and pleural effusion, can help in distinguishing cardiogenic pulmonary edema from COVID-19 pneumonia [28] (Fig. 5).

By contrast, COVID-19-related GGOs may interfere with asymmetrical edema findings such as mitral regurgitation-associated edema or neurogenic edema. In mitral regurgitation due to right upper pulmonary vein-directed reflux, edema findings tend to occur in the right upper lobe [29]. Neurogenic pulmonary edema can be seen in patients with brain injury, and in nearly half of the cases, parenchymal opacities are located in apices [30].

Pulmonary hemorrhage

GGOs and consolidative opacities are also commonly seen in many causes of alveolar hemorrhage, such as collagen-vascular diseases, idiopathic pulmonary hemosiderosis, vasculitis (eosinophilic granulomatosis with polyangiitis, Goodpasture syndrome, granulomatosis with polyangiitis), pulmonary contusion, and anticoagulation therapy [31, 32]. (Fig. 6). Bilateral, focal, or patchy opacities and crazy-paving pattern may be observed in pulmonary hemorrhage. Other than parenchymal opacities, in pulmonary vasculitis, nodules with or without cavitation, centrilobular nodules, a CT halo sign due to perilesional hemorrhage, airway involvement, and pleural effusion may be observed [17, 33]. The reverse halo sign is also reported in granulomatosis with polyangiitis [15]. Associated CT findings, patient history, clinical findings, and serologic tests are essential for differential diagnosis.

Neoplasms

Focal GGOs or opacities with rounded morphology may be encountered in COVID-19 pneumonia [10]. In the presence of focal GGOs, neoplastic processes should also be considered. Preinvasive lesions (atypical adenomatous hyperplasia and adenocarcinoma in situ), early-stage adenocarcinoma (Fig. 7), and multifocal adenocarcinoma (Fig. 8) may have variable imaging features, such as pure GGOs, GGOs in combination with consolidation, nodules surrounded by a halo of GGO (CT halo sign), and GGOs with crazy-paving pattern. Air bronchograms in larger lesions, pleural effusion, and lymphadenopathy can be seen [34‐37]. Similarly, mucinous adenocarcinoma metastases can manifest as focal or multifocal GGOs, consolidations, and nodules with a CT halo sign [38, 39]. Besides tumoral growth, CT halo sign can represent peritumoral hemorrhage in hemorrhagic metastases such as angiosarcoma [17] (Fig. 9).

Organizing pneumonia

Organizing pneumonia can be either cryptogenic or secondary to other lung or systemic diseases (infection, drug toxicity, radiotherapy related, vasculitis, collagen vascular diseases, and interstitial lung disease) [40‐42]. Typical CT findings are bilateral, asymmetrical, peribronchovascular, and subpleural GGOs and consolidations [41, 43]. Uncommonly, crazy-paving pattern may be seen [36]. Another finding, the reverse halo sign, which was also reported in COVID-19 pneumonia, was firstly described in organizing pneumonia [44] (Fig. 10).

Organizing pneumonia may develop during the course of radiotherapy-induced lung disease (RILD) [45]. GGOs and/or consolidation, with superimposed septal thickening causing a crazy-paving pattern, and a CT halo sign may occur in the early phase of RILD [46, 47].

Another cause of secondary organizing pneumonia is drug toxicity. Drug-induced lung diseases may present with variable imaging findings according to the underlying mechanism (hemorrhage, diffuse alveolar damage, edema, and interstitial disease) [48] (Fig. 11).

Pulmonary alveolar proteinosis

The most common CT findings of pulmonary alveolar proteinosis are bilateral, diffuse, or patchy GGOs and consolidations [49]. The crazy-paving pattern (GGOs superimposed with interlobular and intralobular septal thickening), which was recently reported in COVID-19 pneumonia, was initially described in pulmonary alveolar proteinosis [50] (Fig. 12). Increasing opacities and the presence of the pattern in COVID-19 pneumonia is thought to reflect disease progression [12].

Sarcoidosis

COVID-19 pneumonia may resemble atypical sarcoidosis in some cases with patchy or nodular/mass-like GGOs, consolidations, a crazy-paving pattern, and a reverse halo sign (Fig. 13). Typical findings of sarcoidosis such as mediastinal and/or bilateral hilar lymphadenopathies and perilymphatic nodular opacities with upper lobe predilection do not match those of COVID-19 pneumonia [51, 52]. In sarcoidosis, the consolidation ring of the reverse halo sign may have nodularities due to the granulomatous process [15].

Pulmonary infarction

Peripheral GGOs and the reverse halo sign of COVID-19 pneumonia may mimic pulmonary embolism-associated parenchymal changes. Preceding peripheral GGOs may also be present in patients with pulmonary embolism before consolidation develops [53]. Supporting CT findings of the pulmonary thromboembolic disease are peripheral wedge-shaped opacities, a reverse halo sign, atelectasis, and the direct visualization of intraluminal filling defects (Fig. 14). Pleural effusion may be seen [15, 54].

An increased incidence of pulmonary thromboembolism is reported recently in COVID-19 pneumonia [55]. Since unenhanced chest CT is used in the routine practice of COVID-19 diagnosis, one should be alert for parenchymal pulmonary infarction findings. If the patient’s condition suddenly deteriorates, pulmonary thromboembolism should be considered, and pulmonary CT angiography may be obtained.

Interstitial lung diseases

Interstitial lung diseases may also have overlapping CT findings, especially with subacute phase findings of COVID-19 pneumonia. Lower zone and peripherally distributed GGOs are reported in nonspecific interstitial pneumonia (NSIP) and desquamative interstitial pneumonia (DIP) [56, 57]. In NSIP, the crazy-paving pattern and lack of honeycombing might resemble COVID-19 pneumonia [36, 56]. While cystic changes and irregular linear opacities are observed in DIP, honeycombing is also uncommon [57] (Fig. 15).

GGOs are the most common CT finding of lymphocytic interstitial pneumonia (LIP). Unlike in COVID-19 pneumonia, diffuse distribution rather than peripheral distribution, the presence of centrilobular nodules, lymphadenopathy, and cystic airspaces are found in LIP [58].

Acute eosinophilic pneumonia is characterized by bilateral GGOs and consolidations with random or peripheral distribution, interlobular septal thickening, and a crazy-paving pattern (Fig. 16). Pleural effusion is another commonly reported finding [59].

GGOs with lower zone predominance are also common in subacute hypersensitivity pneumonia. Additional findings such as centrilobular nodules, mosaic perfusion, and air-trapping in expiratory images can help in the differential diagnosis [60].

Aspiration pneumonia

Aspiration pneumonia also mostly involves lower lobes and the posterior lung and can manifest as patchy GGOs and/or consolidations. While the findings of bronchiolitis, such as centrilobular nodular opacities and a tree-in-bud pattern, are common in aspiration pneumonia, they are not typically found in COVID-19 pneumonia [61, 62] (Fig. 17). The knowledge of the patient’s pre-existing conditions, general and mental status may help in the differential diagnosis.

Conclusion

Chest CT is an important tool in the diagnosis of COVID-19 pneumonia with high sensitivity rates. However, CT findings of COVID-19 pneumonia are rather nonspecific and variable during the disease course that may resemble numerous infectious and non-infectious diseases. The awareness and knowledge of the radiological features of these entities are essential in early diagnosis and management of precautions during the pandemic. Duration of the symptoms, background and clinical findings of the patient, ancillary imaging findings, and follow-up CT imaging when needed is helpful in the differential diagnosis.

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Zhu N, Zhang D, Wang W et al (2019) A novel coronavirus from patients with pneumonia in China. N Engl J Med 382:727–733CrossRef

Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506PubMedPubMedCentralCrossRef

Coronavirus Disease (2019) https://www.who.int/emergencies/diseases/novel-coronavirus-2019/. Accessed 19 May 2020

Ai T, Yang Z, Hou H et al (2020) Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. https://doi.org/10.1148/radiol.2020200642CrossRefPubMedPubMedCentral

Fang Y, Zhang H, Xie J et al (2020) Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology. https://doi.org/10.1148/radiol.2020200432CrossRefPubMed

Arevalo-Rodriguez I, Buitrago-Garcia D, Simancas-Racines D et al (2020) False-negative results of initial RT-PCR assays for COVID-19: a systematic review. https://www.medrxiv.org/content/https://doi.org/10.1101/2020.04.16.20066787v1

Kim H, Hong H, Yoon SH (2020) Diagnostic performance of CT and reverse transcriptase-polymerase chain reaction for coronavirus disease 2019: a meta-analysis. Radiology. https://doi.org/10.1148/radiol.2020201343CrossRefPubMedPubMedCentral

Ye Z, Zhang Y, Wang Y, Huang Z, Song B (2020) Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review. Eur Radiol. https://doi.org/10.1007/s00330-020-06801-0CrossRefPubMedPubMedCentral

Zhou S, Zhu T, Wang Y, Xia L (2020) Imaging features and evolution on CT in 100 COVID-19 pneumonia patients in Wuhan, China. Eur Radiol. https://doi.org/10.1007/s00330-020-06879-6CrossRefPubMedPubMedCentral

10.

Chung M, Bernheim A, Mei X et al (2020) CT imaging features of 2019 novel coronavirus (2019-NCoV). Radiology 295(1):202–207PubMedCrossRef

11.

Shi H, Han X, Jiang N et al (2020) Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 20(4):425–434PubMedPubMedCentralCrossRef

12.

Pan F, Ye T, Sun P et al (2020) Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia. Radiology 295(3):715–721PubMedCrossRef

13.

Huang G, Gong T, Wang G et al (2020) Timely diagnosis and treatment shortens the time to resolution of coronavirus disease (COVID-19) pneumonia and lowers the highest and last CT scores from sequential chest CT. AJR Am J Roentgenol. https://doi.org/10.2214/AJR.20.23078CrossRefPubMedPubMedCentral

14.

Bai HX, Hsieh B, Xiong Z et al (2020) Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology. https://doi.org/10.1148/radiol.2020200823CrossRefPubMed

15.

Marchiori E, Zanetti G, Escuissato DL et al (2012) Reversed halo sign: High-resolution CT scan findings in 79 patients. Chest 141(5):1260–1266PubMedCrossRef

16.

Alves GRT, Marchiori E, Irion K et al (2016) The halo sign: HRCT findings in 85 patients. J Bras Pneumol 42(6):435–439PubMedPubMedCentralCrossRef

17.

Primack SL, Hartman TE, Lee KS, Müller NL (1994) Pulmonary nodules and the CT halo sign. Radiology 190(2):513–515PubMedCrossRef

18.

Franquet T (2011) Imaging of pulmonary viral pneumonia. Radiology 260(1):18–39PubMedCrossRef

19.

Koo HJ, Lim S, Choe J, Choi SH, Sung H, Do KH (2018) Radiographic and CT features of viral pneumonia. Radiographics 38(3):719–739PubMedCrossRef

20.

Wong KT, Antonio GE, Hui DSC et al (2003) Severe acute respiratory syndrome: Radiographic appearances and pattern of progression in 138 patients. Radiology 228(2):401–406PubMedCrossRef

21.

Paul NS, Roberts H, Butany J et al (2004) Radiologic pattern of disease in patients with severe acute respiratory syndrome: the Toronto experience. Radiographics 24(2):553–563PubMedCrossRef

22.

Ajlan AM, Ahyad RA, Jamjoom LG, Alharthy A, Madani TA (2014) Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings. AJR Am J Roentgenol 203(4):782–787PubMedCrossRef

23.

Miller WT, Mickus TJ, Barbosa E, Mullin C, Van Deerlin VM, Shiley KT (2011) CT of viral lower respiratory tract infections in adults: comparison among viral organisms and between viral and bacterial infections. AJR Am J Roentgenol 197(5):1088–1095PubMedCrossRef

24.

Fujii T, Nakamura T, Iwamoto A (2007) Pneumocystis pneumonia in patients with HIV infection: clinical manifestations, laboratory findings, and radiological features. J Infect Chemother 13(1):1–7PubMedCrossRef

25.

Connolly JE, McAdams HP, Erasmus JJ, Rosado-de-Christenson ML (1999) Opportunistic fungal pneumonia. J Thorac Imaging 14:51–62PubMedCrossRef

26.

Orlowski HLP, McWilliams S, Mellnick VM et al (2017) Imaging spectrum of invasive fungal and fungal-like infections. Radiographics 37(1119–1134):27

27.

Lansbury L, Lim B, Baskaran V et al (2020) Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect 81:266–275PubMedPubMedCentralCrossRef

28.

Storto ML, Kee ST, Golden JA, Webb WR (1995) Hydrostatic pulmonary edema: high-resolution CT findings. AJR Am J Roentgenol 165(4):817–820PubMedCrossRef

29.

Gurney JW, Goodman LR (1989) Pulmonary edema localized in the right upper lobe accompanying mitral regurgitation. Radiology 171(2):397–399PubMedCrossRef

30.

Ell SR (1991) Neurogenic pulmonary edema. A review of the literature and a perspective. Invest Radiol 26(5):499–506PubMedCrossRef

31.

Chung MP, Yi CA, Lee HY, Han J, Lee KS (2010) Imaging of pulmonary vasculitis. Radiology 255(2):322–341PubMedCrossRef

32.

Kaewlai R, Avery LL, Asrani AV, Novelline RA (2008) Multidetector CT of blunt thoracic trauma. Radiographics 28(6):1555–1570PubMedCrossRef

33.

Feragalli B, Mantini C, Sperandeo M et al (2016) The lung in systemic vasculitis: radiological patterns and differential diagnosis. Br J Radiol 89(1061):20150992PubMedPubMedCentralCrossRef

34.

Mirtcheva RM, Vazquez M, Yankelevitz DF, Henschke CI (2002) Bronchioloalveolar carcinoma and adenocarcinoma with bronchioloalveolar features presenting as ground-glass opacities on CT. Clin Imaging 26(2):95–100PubMedCrossRef

35.

Lee HY, Choi Y-L, Lee KS et al (2014) Pure ground-glass opacity neoplastic lung nodules: histopathology, imaging, and management. AJR Am J Roentgenol 202(3):224–233CrossRef

36.

Rossi SE, Erasmus JJ, Volpacchio M, Franquet T, Castiglioni T, Mcadams HP (2003) “Crazy-paving” pattern at thin-section CT of the lungs: radiologic-pathologic overview. Radiographics 23(6):1509–1519PubMedCrossRef

37.

Gaikwad A, Gupta A, Hare S et al (2012) Primary adenocarcinoma of lung: a pictorial review of recent updates. Eur J Radiol 81(12):4146–4155PubMedCrossRef

38.

Seo JB, Im JG, Goo JM, Chung MJ, Kim MY (2001) Atypical pulmonary metastases: spectrum of radiologic findings. Radiographics 21(2):403–417PubMedCrossRef

39.

Gaeta M, Volta S, Scribano E, Loria G, Vallone A, Pandolfo I (1996) Air-space pattern in lung metastasis from adenocarcinoma of the GI tract. J Comput Assist Tomogr 20(2):300–304PubMedCrossRef

40.

Baque-Juston M, Pellegrin A, Leroy S, Marquette CH, Padovani B (2014) Organizing pneumonia: what is it? A conceptual approach and pictorial review. Diagn Interv Imaging 95(9):771–777PubMedCrossRef

41.

Roberton BJ, Hansell DM (2011) Organizing pneumonia: a kaleidoscope of concepts and morphologies. Eur Radiol 21(11):2244–2254PubMedCrossRef

42.

Epler GR (2011) Bronchiolitis obliterans organizing pneumonia, 25 years: a variety of causes, but what are the treatment options? Expert Rev Respir Med 5(3):353–361PubMedCrossRef

43.

Lee JW, Lee KS, Lee HY et al (2010) Cryptogenic organizing pneumonia: serial high-resolution CT findings in 22 patients. AJR Am J Roentgenol 195(4):916–922PubMedCrossRef

44.

Kim SJ, Lee KS, Ryu YH et al (2003) Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: diagnostic implications. AJR Am J Roentgenol 180(5):1251–1254PubMedCrossRef

45.

Takigawa N, Segawa Y, Saeki T et al (2000) Bronchiolitis obliterans organizing pneumonia syndrome in breast-conserving therapy for early breast cancer: radiation-induced lung toxicity. Int J Radiat Oncol Biol Phys 48(3):751–755PubMedCrossRef

46.

Benveniste MFK, Welsh J, Godoy MCB et al (2013) New era of radiotherapy: an update in radiation-induced lung disease. Clin Radiol 68:275–290CrossRef

47.

Choi YW, Munden RF, Erasmus JJ et al (2004) Effects of radiation therapy on the lung: radiologic appearances and differential diagnosis. Radiographics 24(4):985–998PubMedCrossRef

48.

Rossi SE, Erasmus JJ, McAdams HP, Sporn TA, Goodman PC (2000) Pulmonary drug toxicity: Radiologic and pathologic manifestations. Radiographics 20(5):1245–1259PubMedCrossRef

49.

Holbert JM, Costello P, Li W, Hoffman RM, Rogers RM (2001) CT features of pulmonary alveolar proteinosis. AJR Am J Roentgenol 176(5):1287–1294PubMedCrossRef

50.

Murch CR, Carr DH (1989) Computed tomography appearances of pulmonary alveolar proteinosis. Clin Radiol 40(3):240–243PubMedCrossRef

51.

Criado E, Sánchez M, Ramírez J et al (2010) Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation. Radiographics 30(6):1567–1586PubMedCrossRef

52.

Collins J, Stern EJ (1997) Ground-glass opacity at CT: the ABCs. AJR Am J Roentgenol 169(2):355–367PubMedCrossRef

53.

Engelke C, Schaefer-Prokop C, Schirg E, Freihorst J, Grubnic S, Prokop M (2002) High-resolution CT and CT angiography of peripheral pulmonary vascular disorders. Radiographics 22(4):739–764PubMedCrossRef

54.

Shah AA, Davis SD, Gamsu G, Intriere L (1999) Parenchymal and pleural findings in patients with and patients without acute pulmonary embolism detected at spiral CT. Radiology 211(1):147–153PubMedCrossRef

55.

Grillet F, Behr J, Calame P, Aubry S, Delabrousse E (2020) Acute pulmonary embolism associated with COVID-19 pneumonia detected by pulmonary CT angiography. Radiology. https://doi.org/10.1148/radiol.2020201544CrossRefPubMed

56.

Kim TS, Lee KS, Chung MP et al (1998) Nonspecific interstitial pneumonia with fibrosis: high-resolution CT and pathologic findings. AJR Am J Roentgenol 171(6):1645–1650PubMedCrossRef

57.

Hartman TE, Primack SL, Swensen SJ, Hansell D, McGuinness G, Muller NL (1993) Desquamative interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 187(3):787–790PubMedCrossRef

58.

Johkoh T, Müller NL, Pickford HA et al (1999) Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 212(2):567–572PubMedCrossRef

59.

Daimon T, Johkoh T, Sumikawa H et al (2008) Acute eosinophilic pneumonia: thin-section CT findings in 29 patients. Eur J Radiol 65(3):462–467PubMedCrossRef

60.

Hansell DM, Wells AU, Padley SPG, Müller NL (1996) Hypersensitivity pneumonitis: correlation of individual CT patterns with functional abnormalities. Radiology 199(1):123–128PubMedCrossRef

61.

Komiya K, Ishii H, Umeki K et al (2013) Computed tomography findings of aspiration pneumonia in 53 patients. Geriatr Gerontol Int 13:580–585PubMedCrossRef

62.

Franquet T, Giménez A, Rosón N, Torrubia S, Sabaté JM, Pérez C (2000) Aspiration diseases: findings, pitfalls, and differential diagnosis. Radiographics 20:673–685PubMedCrossRef

Titel: COVID-19 pneumonia: the great radiological mimicker
verfasst von: Selin Ardali Duzgun
Gamze Durhan
Figen Basaran Demirkazik
Meltem Gulsun Akpinar
Orhan Macit Ariyurek
Publikationsdatum: 01.12.2020
Verlag: Springer Berlin Heidelberg
Schlagwörter: COVID-19
Diagnostik in der Infektiologie
Erschienen in: Insights into Imaging / Ausgabe 1/2020
Elektronische ISSN: 1869-4101
DOI: https://doi.org/10.1186/s13244-020-00933-z

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

COVID-19 pneumonia: the great radiological mimicker

Abstract

Publisher's Note

Introduction

CT findings of COVID-19 pneumonia